...
search icon
valn-img

Valneva SE ADR Share Price

VALN
NSQ
$10.08
+$0.06
(0.6%)
1D
Industry: Biotechnology Sector: Health Care

Valneva SE ADR Analyst Forecast

Valneva SE ADR Share Price Chart

Valneva SE ADR Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$870.50M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
12.20K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.20
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.43 L
$12.25 H
$10.08

About Valneva SE ADR, Common Stock

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. The company was founded in 1998 and is based in Saint-Herblain, France. more

Industry: BiotechnologySector: Health Care

Valneva SE ADR Stock Returns

Time FrameVALNSectorS&P500
1-Week Return6.22%-1.08%-1.38%
1-Month Return0.45%-0.47%-1.81%
3-Month Return9.21%2.13%1.38%
6-Month Return-9.68%17.04%5.68%
1-Year Return29.4%6.56%11.74%
3-Year Return-21.74%16.78%65.15%
5-Year Return-64.44%34.34%73.68%

Valneva SE ADR Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue110.32M348.08M361.30M153.71M169.58M[{"date":"2020-12-31","value":30.53,"profit":true},{"date":"2021-12-31","value":96.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.54,"profit":true},{"date":"2024-12-31","value":46.94,"profit":true}]
Cost of Revenue54.30M187.92M324.44M100.88M98.54M[{"date":"2020-12-31","value":16.74,"profit":true},{"date":"2021-12-31","value":57.92,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":31.09,"profit":true},{"date":"2024-12-31","value":30.37,"profit":true}]
Gross Profit56.02M160.16M36.86M52.84M71.04M[{"date":"2020-12-31","value":34.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":23.02,"profit":true},{"date":"2023-12-31","value":32.99,"profit":true},{"date":"2024-12-31","value":44.35,"profit":true}]
Gross Margin50.78%46.01%10.20%34.37%41.89%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":90.62,"profit":true},{"date":"2022-12-31","value":20.09,"profit":true},{"date":"2023-12-31","value":67.69,"profit":true},{"date":"2024-12-31","value":82.5,"profit":true}]
Operating Expenses111.13M221.56M150.31M134.92M57.71M[{"date":"2020-12-31","value":50.16,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.84,"profit":true},{"date":"2023-12-31","value":60.9,"profit":true},{"date":"2024-12-31","value":26.05,"profit":true}]
Operating Income(55.11M)(61.39M)(113.44M)(82.09M)13.33M[{"date":"2020-12-31","value":-413.43,"profit":false},{"date":"2021-12-31","value":-460.55,"profit":false},{"date":"2022-12-31","value":-851.04,"profit":false},{"date":"2023-12-31","value":-615.81,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(20.80M)(25.30M)(50.17M)(33.75M)(46.44M)[{"date":"2020-12-31","value":-2080200000,"profit":false},{"date":"2021-12-31","value":-2530300000,"profit":false},{"date":"2022-12-31","value":-5016600000,"profit":false},{"date":"2023-12-31","value":-3375300000,"profit":false},{"date":"2024-12-31","value":-4643800000,"profit":false}]
Pre-Tax Income(65.30M)(69.98M)(144.81M)(98.63M)(11.49M)[{"date":"2020-12-31","value":-6530200000,"profit":false},{"date":"2021-12-31","value":-6997900000,"profit":false},{"date":"2022-12-31","value":-14481500000,"profit":false},{"date":"2023-12-31","value":-9862900000,"profit":false},{"date":"2024-12-31","value":-1148600000,"profit":false}]
Income Taxes(909.00K)3.45M(1.54M)2.80M761.00K[{"date":"2020-12-31","value":-26.38,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-44.57,"profit":false},{"date":"2023-12-31","value":81.25,"profit":true},{"date":"2024-12-31","value":22.08,"profit":true}]
Income After Taxes(64.39M)(73.42M)(143.28M)(101.43M)(12.25M)[{"date":"2020-12-31","value":-6439300000,"profit":false},{"date":"2021-12-31","value":-7342500000,"profit":false},{"date":"2022-12-31","value":-14327900000,"profit":false},{"date":"2023-12-31","value":-10142900000,"profit":false},{"date":"2024-12-31","value":-1224700000,"profit":false}]
Income From Continuous Operations(64.39M)(73.42M)(143.28M)(113.47M)(12.25M)[{"date":"2020-12-31","value":-6439300000,"profit":false},{"date":"2021-12-31","value":-7342500000,"profit":false},{"date":"2022-12-31","value":-14327900000,"profit":false},{"date":"2023-12-31","value":-11347500000,"profit":false},{"date":"2024-12-31","value":-1224700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(64.39M)(73.42M)(143.28M)(101.43M)(12.25M)[{"date":"2020-12-31","value":-6439300000,"profit":false},{"date":"2021-12-31","value":-7342500000,"profit":false},{"date":"2022-12-31","value":-14327900000,"profit":false},{"date":"2023-12-31","value":-10142900000,"profit":false},{"date":"2024-12-31","value":-1224700000,"profit":false}]
EPS (Diluted)(1.32)(1.69)(2.63)(1.33)(0.13)[{"date":"2020-12-31","value":-132.46,"profit":false},{"date":"2021-12-31","value":-168.67,"profit":false},{"date":"2022-12-31","value":-262.58,"profit":false},{"date":"2023-12-31","value":-133,"profit":false},{"date":"2024-12-31","value":-13.25,"profit":false}]

Valneva SE ADR Ratios

Valneva SE ADR Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

VALN
Current Ratio 1.78
Quick Ratio 1.36

Valneva SE ADR Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VALN
ROA (LTM) -9.64%
ROE (LTM) -55.53%

Valneva SE ADR Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VALN
Debt Ratio Lower is generally better. Negative is bad. 0.66
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.34

Valneva SE ADR Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VALN
Trailing PE NM
Forward PE 666.67
P/S (TTM) 4.84
P/B 4.89
Price/FCF NM
EV/R 4.21
EV/Ebitda 26.94

FAQs

What is Valneva SE ADR share price today?

Valneva SE ADR (VALN) share price today is $10.08

Can Indians buy Valneva SE ADR shares?

Yes, Indians can buy shares of Valneva SE ADR (VALN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VALN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Valneva SE ADR be purchased?

Yes, you can purchase fractional shares of Valneva SE ADR (VALN) via the Vested app. You can start investing in Valneva SE ADR (VALN) with a minimum investment of $1.

How to invest in Valneva SE ADR shares from India?

You can invest in shares of Valneva SE ADR (VALN) via Vested in three simple steps:

  • Click on Sign Up or Invest in VALN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Valneva SE ADR shares
What is Valneva SE ADR 52-week high and low stock price?

The 52-week high price of Valneva SE ADR (VALN) is $12.25. The 52-week low price of Valneva SE ADR (VALN) is $5.43.

What is Valneva SE ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Valneva SE ADR (VALN) is

What is Valneva SE ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Valneva SE ADR (VALN) is 4.89

What is Valneva SE ADR dividend yield?

The dividend yield of Valneva SE ADR (VALN) is 0.00%

What is the Market Cap of Valneva SE ADR?

The market capitalization of Valneva SE ADR (VALN) is $870.50M

What is Valneva SE ADR's stock symbol?

The stock symbol (or ticker) of Valneva SE ADR is VALN

How Can Investors Use Valneva SE ADR Share Price Data for Long-Term Investment Decisions?

Consider the share price of Valneva SE ADR as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Valneva SE ADR has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Valneva SE ADR shares for Indian investors?

When investing in Valneva SE ADR shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Valneva SE ADR stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Valneva SE ADR share price with other stocks in the same sector?

Rather than merely checking the share price of Valneva SE ADR and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Valneva SE ADR stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top